Choosing Migraine Abortive Medications: Key Factors for Personalized Treatment

Selecting the right acute migraine medication requires balancing efficacy, safety, and patient preferences.

Patient-Specific Factors

  • Treatment History: Prior response and tolerability guide choices.
  • Comorbidities: Cardiovascular disease contraindicates triptans/ergots; renal/hepatic impairment affects dosing.
  • Pregnancy/Lactation: Limits options (e.g., avoid NSAIDs in 3rd trimester, triptans limited data).

Medication Characteristics

  • Mechanism: Triptans (5-HT1B/1D agonists), NSAIDs (COX inhibition), gepants (CGRP antagonists), ditans (5-HT1F agonists).
  • Onset/Duration: Oral (30–60 min), nasal/injectable (10–15 min) for rapid relief; longer half-life reduces recurrence.
  • Side Effects: Triptans (chest tightness, paresthesia), NSAIDs (GI bleed), antiemetics (sedation).

Safety & Interactions

  • Drug interactions (e.g., triptans + MAOIs, SSRIs → serotonin syndrome risk).
  • Contraindications (uncontrolled HTN, ischemic heart disease for triptans).

Route of Administration

  • Oral: Standard, but nausea may impair absorption.
  • Nasal/Injectable: Bypass GI; useful with severe nausea/vomiting.

Patient Preference & Practicality

Ease of use, discretion, cost, insurance coverage, and timing of attacks (e.g., nocturnal vs. daytime) all influence adherence.

Shared decision-making between patient and clinician optimizes outcomes.

Migraine - Related Articles